Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines

Due to poor specificity, the current pharmacotherapy of atherosclerosis has limited therapeutic efficacy. Here, the authors show that a macrophage-biomimetic nanomedicine effectively alleviates atherosclerosis via targeted pharmacotherapy and sequestration of proinflammatory cytokines and chemokines...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cheng Gao, Qiaoxian Huang, Conghui Liu, Cheryl H. T. Kwong, Ludan Yue, Jian-Bo Wan, Simon M. Y. Lee, Ruibing Wang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/c2130094bf8f43128180c567fdb490e3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!